PHOENIX (AP) — Arizona Gov. Doug Ducey on Thursday warned that a “storm is ahead” as coronavirus cases climb in the state, but defended new guidelines for in-person school instruction that will let students remain in class far beyond what earlier guidance would have recommended.
The Republican governor insisted that his administration consulted with public education and health officials before making the decision to ease guidance for when schools should consider ending in-person instruction and returning to online classes.
The more we talk about how different individuals from all the parts of the world are trying their best to make a mark in their respective fields, the more we feel it is spoken less about. Similarly, the fitness world too in the past decade has given birth to some of the most high-performing and passionate bodybuilders and fitness experts who have gone ahead and created their own unique niche. One such growing name is Said Sergeyevich Shavershian, aka Chestbrah, as he is well-known across the online world. This young and passionate fitness lover and bodybuilder started with his late and legendary brother and pioneer of the aesthetic movements Aziz Sergeyevich Shavershian for creating a historical revolution in the fitness industry.
Chestbrah is a 34-year-old bodybuilder and a well-known name in the fitness world, who dived deep into bodybuilding from the age of 18. He and his family migrated from Russia and moved to Australia when he was only 6 years old. After finishing studies in high school, he earned his degree in operations in business management and used the degree to prepare himself in the fitness world and market himself and his brand to become big in the same.
Today, he is a fitness entrepreneur as well who owns two online businesses; one is ‘Aesthetic Supplements’, which sells best quality aesthetic supplements, running for the past one year successfully and the other is ‘Shavershian Fitness’, which is an online clothing brand, gaining great success from the past five years. Both of these businesses of Chestbrah are world-renowned and established. His late brother Aziz and him together started the aesthetic movements that is today in the fitness industry.
For the last 10 years, Chestbrah has been working consistently to build his legacy and create a massive movement in the fitness scene to inspire the young generation to chase their dreams, goals and fitness passion and craze. He is also excited to be sailing the WBFF pro card and win the same in the coming months as he is preparing for a big major competition, where last time he was placed at number 4. This time, he is even more excited to move ahead in the competition.
Said was also a Head judge for JEFF SEID CLASSIC international fitness show and we expecting him to see once again in 2021 along with jeff SEID and B. O. D Hamdan Pathan in India.
Disclaimer: This is a company press release. No HT journalist is involved in creation of this content.
Some immune systems have responded to coronavirus disease 2019 (COVID-19) infections by going into overdrive, resulting in an overzealous inflammatory response referred to as a cytokine storm. In a retrospective study of nearly 6,000 patients, researchers from The Feinstein Institutes for Medical Research and Northwell COVID-19 Research Consortium have identified the most effective immunomodulatory therapies to treat patients with evidence of this cytokine storm and improve patient survival.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201020006139/en/
Dr. Negin Hajizadeh and colleagues. (Credit: Feinstein Institutes for Medical Research)
A multidisciplinary team of investigators, led by Negin Hajizadeh, MD, a pulmonary and critical care physician, and associate professor at the Feinstein Institutes, analyzed the electronic health records of hospitalized COVID-19 patients across 12 of Northwell Health hospitals – New York State’s largest health system – between March 1 and April 24, 2020. The results were published today in CHEST, by Sonali Narain, MD, assistant professor at the Feinstein Institutes, corresponding author, and team.
Patients were divided into one of six groups; no immunomodulatory treatment (standard of care), patients who received intravenous corticosteroids, anti-interleukin 6 antibody therapy (tocilizumab) or anti-interleukin-1 therapy (anakinra) alone or in combination with corticosteroids.
The results show that the most effective treatment was the combination of corticosteroids – such as dexamethasone – with tocilizumab when compared to standard of care. Additionally, there was an improvement if corticosteroids were used alone, or in combination with tocilizumab or anakinra when compared with standard of care.
“Cytokine storms are a hallmark for many COVID-19 patients and are associated with the most severe form of this illness,” said Dr. Hajizadeh, associate professor at the Zucker School of Medicine at Hofstra/Northwell and co-senior author on the paper. “Our findings suggest that with the intervention of certain drugs like corticosteroids, we can battle the cytokine storm and improve outcomes to the point that we believe we have found a new standard of care for seriously ill patients.”
Overall, there were twice as many males as females in the cohorts, and more than 65 percent had never smoked. Contradictory to previous reports, the Black population was associated with better survival compared to white patients. Additionally, the most common comorbidities across the groups of patients that experienced a cytokine storm include:
Hypertension (44-59 percent);
Diabetes (32-46 percent);
Cardiovascular disease (5-14 percent);
Chronic kidney disease (5-12 percent);
Cancer (5-11 percent);
Asthma (3-12 percent).
“Dr. Hajizadeh’s major COVID-19 research study gives timely and crucial new knowledge about using currently available anti-inflammatory drugs,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes. “This information will help others save lives.”
The researchers hope that the findings are useful for frontline providers to care for severely ill COVID-19 patients and to aid in the future design of large randomized controlled clinical trials, the gold standard of medical research.
About the Feinstein Institutes
The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer